Glymidine sodium

This classification denotes an anti-diabetic agent with the molecular formula C13H14N3O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QPY3C057X1, chemically known as benzenesulfonamide, n-(5-(2-methoxyethoxy)-2-pyrimidinyl)-, sodium salt but more generally known as glymidine sodium, which bears US NIH Compound Identifier 18956. European Medicines Agency schedules Glymidine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07954MIG. The term GLYMIDINE SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). Most nations, for tariff and trade purposes, schedule glymidine sodium under HS 29350090. As of Q4 2014, GLYMIDINE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: COCCOC1CNC(NC1)[N-]S(=O)(=O)C2CCCCC2.[NA+].